Cargando…
Tablet or capsule form of generic mycophenolate mofetil (My-Rept(®)) after liver transplantation: a prospective randomized trial
BACKGROUND: Tablet and capsule forms have advantages and disadvantages in the market. Generally, the tablet form (500 mg) of mycophenolate mofetil (MMF) is more convenient for drug ingestion and more cost-effective than the capsule form (250 mg). We examined the efficacy and safety of MMF in its dif...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617558/ https://www.ncbi.nlm.nih.gov/pubmed/31308630 http://dx.doi.org/10.2147/DDDT.S204056 |